Dutch join backlash at expensive drugs by making their own In a radiation-proof room at the Erasmus Medical Center in Rotterdam, Emar Thomasa sits behind shielded glass as he carefully measures and mixes lutetium octreotate, an intravenous treatment for certain types of cancer.

redirecting to
https://www.reuters.com/article/us-netherlands-pharmaceuticals-insight/dutch-join-backlash-at-expensive-drugs-by-making-their-own-idUSKCN1QP0M4?feedType=RSS&feedName=worldNews